<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="97520">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01995357</url>
  </required_header>
  <id_info>
    <org_study_id>CP244</org_study_id>
    <nct_id>NCT01995357</nct_id>
  </id_info>
  <brief_title>The Influence of Baseplate Adhesive on the Degree of Leakage</brief_title>
  <official_title>The Influence of Base Plate Adhesive Type, Shape and Application on Degree of Leak-age - a Randomized Controlled Trial in Subjects With Ileostomy and Colostomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <authority>Denmark: Danish Health and Medicines Authority</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The influence of the baseplate adhesive type, shape and application is investigated with
      regard to the degree of leakage.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Degree of leakage</measure>
    <time_frame>10 (- 2 days)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Degree of leakage measured with a 32 point scale</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">26</enrollment>
  <condition>Colostomy Stoma</condition>
  <condition>Ileostomy Stoma</condition>
  <arm_group>
    <arm_group_label>First Coloplast Teast A; then Coloplast Test B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>There are six arms in this study. The first part of the study investigated the two test products and one comparator product. In the second part of the study the subjects test the two test products again but receive training meanwhile.
The test sequence in this arm is:
Coloplast Test A; Coloplast Test B; Standard product; Training + Coloplast Test A; Training + Coloplast Test B</description>
  </arm_group>
  <arm_group>
    <arm_group_label>First Coloplast Test A; Then Standard product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>There are six arms in this study. The first part of the study investigated the two test products and one comparator product. In the second part of the study the subjects test the two test products again but receive training meanwhile.
The test sequence in this arm is:
Coloplast Test A; Standard product; Coloplast Test B; ; Training + Coloplast Test A; Training + Coloplast Test B</description>
  </arm_group>
  <arm_group>
    <arm_group_label>First Coloplast Test B; Then Colopast Test A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>There are six arms in this study. The first part of the study investigated the two test products and one comparator product. In the second part of the study the subjects test the two test products again but receive training meanwhile.
The test sequence in this arm is:
Coloplast Test B; Coloplast Test A; Standard product; Training + Coloplast Test B; Training + Coloplast Test A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>First Coloplast Test B; Then Standard product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>There are six arms in this study. The first part of the study investigated the two test products and one comparator product. In the second part of the study the subjects test the two test products again but receive training meanwhile.
The test sequence in this arm is:
Coloplast Test b; Standard product; Coloplast Test A; Training + Coloplast Test B; Training + Coloplast Test A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>First Standard product; Then Coloplast Test A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>There are six arms in this study. The first part of the study investigated the two test products and one comparator product. In the second part of the study the subjects test the two test products again but receive training meanwhile.
The test sequence in this arm is:
Standard product; Coloplast Test A; Coloplast Test B; ; Training + Coloplast Test A; Training + Coloplast Test B</description>
  </arm_group>
  <arm_group>
    <arm_group_label>First Standard Product, Then Coloplast test B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>There are six arms in this study. The first part of the study investigated the two test products and one comparator product. In the second part of the study the subjects test the two test products again but receive training meanwhile.
The test sequence in this arm is:
Standard product; Coloplast Test B; Coloplast Test A; ; Training + Coloplast Test B; Training + Coloplast Test A</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coloplast Test A</intervention_name>
    <description>Coloplast Test A is a newly developed ostomy appliance</description>
    <arm_group_label>First Coloplast Teast A; then Coloplast Test B</arm_group_label>
    <arm_group_label>First Coloplast Test A; Then Standard product</arm_group_label>
    <arm_group_label>First Coloplast Test B; Then Colopast Test A</arm_group_label>
    <arm_group_label>First Coloplast Test B; Then Standard product</arm_group_label>
    <arm_group_label>First Standard product; Then Coloplast Test A</arm_group_label>
    <arm_group_label>First Standard Product, Then Coloplast test B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coloplast Test B</intervention_name>
    <description>Coloplast Test B is a newly developed ostomy appliance.</description>
    <arm_group_label>First Coloplast Teast A; then Coloplast Test B</arm_group_label>
    <arm_group_label>First Coloplast Test A; Then Standard product</arm_group_label>
    <arm_group_label>First Coloplast Test B; Then Colopast Test A</arm_group_label>
    <arm_group_label>First Coloplast Test B; Then Standard product</arm_group_label>
    <arm_group_label>First Standard product; Then Coloplast Test A</arm_group_label>
    <arm_group_label>First Standard Product, Then Coloplast test B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard product</intervention_name>
    <description>Standard product is the subjects usual product. Only subjects that usually use the CE-marked commercially available SenSura 1-piece flat and SenSura Mio 1-piece are included in the investigation.</description>
    <arm_group_label>First Coloplast Teast A; then Coloplast Test B</arm_group_label>
    <arm_group_label>First Coloplast Test A; Then Standard product</arm_group_label>
    <arm_group_label>First Coloplast Test B; Then Colopast Test A</arm_group_label>
    <arm_group_label>First Coloplast Test B; Then Standard product</arm_group_label>
    <arm_group_label>First Standard product; Then Coloplast Test A</arm_group_label>
    <arm_group_label>First Standard Product, Then Coloplast test B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Have given written informed consent and signed letter of authority

          2. Be at least 18 years of age and have full legal capacity

          3. Have had their ileostomy/colostomy for at least 3 months

          4. Have a stoma with a diameter between 15 and 36 mm

          5. Be able to handle the products themselves

          6. Be able to use a custom cut product

          7. Normally experience faeces under the base plate at least 3 times during 2 weeks

          8. Currently using SenSura 1-piece flat, open or closed bag, pre-cut or custom-cut or
             SenSura Mio 1-piece flat, closed bag, pre-cut or custom cut

          9. Be willing to test the test products without using paste and/or ring

         10. Be willing to use minimum 1 test product every second day, i.e. maximum 48 hours wear
             time per prod-uct

         11. Be suitable for participation in the investigation

         12. Be able to present a negative result of a pregnancy test - for women of childbearing
             age

        Exclusion Criteria:

          1. Are currently receiving or have within the past 2 months received radio- and/or
             chemotherapy

          2. Are currently receiving or have within the past month received local or systemic
             steroid treatment in the peristomal area

          3. Are pregnant or breastfeeding

          4. Are participating in other interventional clinical investigations or have previously
             participated in this investigation

          5. Use irrigation during the investigation (flush the intestines with water)

          6. Are currently suffering from peristomal skin problems, i.e. bleeding and/or broken
             skin (assessed by the investigator/investigator representative)

          7. Have a loop stoma

          8. Have known hypersensitivity towards any of the test products (including adhesive
             remover)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Birte P Jakobsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Coloplast A/S</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lea JT Rasmussen</last_name>
    <phone>+45 4911 4943</phone>
    <email>dklejtr@coloplast.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Coloplast A/S</name>
      <address>
        <city>Humlebæk</city>
        <zip>3050</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>November 21, 2013</lastchanged_date>
  <firstreceived_date>November 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
